According to analyst projections, syn’s forecast low is $2.50 with $2.50 as the target high. In this case, analysts estimate an annual eps growth of 80.30% for the year and 15.40% for the next year.
Cash and cash equivalents as of september 30, 2021 totaled $72.1 million, an increase of $65.9 million from december.
Syn amex stock forecast. Health technology, biotechnology position proposed: Since then, syn stock has decreased by 9.5% and is now trading at $0.3258. Health technology, biotechnology position proposed:
Press release reported on 08/05/21 that synthetic biologics reports second quarter 2021 operational highlights and financial results;. All the more reason to consider synthetic biologics inc. The analyst firm set a price target for 0.00 expecting syn to fall to within 12 months.
The company’s stock price has collected 0.48% of gains in the last five trading sessions. The latest price target for synthetic biologics ( amex: The jump to weekly highs of 0.3600 on friday, 12/03/21 added 0.06% to.
Buy ready (0.5950) 1st partial take profit: (syn) stock quote, history, news and other vital information to help you with your stock trading and investing. Instantly syn was in green as seen at the end of in last trading.
Syn) was reported by maxim group on march 12, 2021. Find the latest synthetic biologics, inc. Synthetic biologics (amex:syn) reported quarterly losses of $ (0.02) per share which met the analyst consensus estimate.
(syn) now synthetic biologics inc. (amex:syn)’s traded shares stood at 0.54 million during the latest session, with the company’s beta value hitting 1.79. The stock opened with a gain of 17.65% at $0.40 and touched an intraday high of $0.3979, rising 17.03% against the last close of $0.34.
Buy ready (0.5950) 1st partial take profit: The stock went to a low of $0.3619 during the session. The volatility ratio for the week stands at 4.44% while the volatility levels for the past 30 days are set at 4.92% for synthetic biologics inc.
0 komentar:
Posting Komentar